ClinicalTrials.gov record
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
ClinicalTrials.gov ID: NCT00799903
Public ClinicalTrials.gov record NCT00799903. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.
Study identification
- NCT ID
- NCT00799903
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 15,828 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2008 (Type not available)
- Primary completion
- Oct 1, 2013 (Actual)
- Completion
- Oct 17, 2013 (Actual)
- Last update posted
- Aug 10, 2017
2008 – 2013
United States locations
- U.S. sites
- 155
- U.S. states
- 40
- U.S. cities
- 135
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35235 | — |
| GSK Investigational Site | Birmingham | Alabama | 35294-0007 | — |
| GSK Investigational Site | Huntsville | Alabama | 35801 | — |
| GSK Investigational Site | Anchorage | Alaska | 99508 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72204 | — |
| GSK Investigational Site | Concord | California | 94520 | — |
| GSK Investigational Site | Lomita | California | 90717 | — |
| GSK Investigational Site | Los Angeles | California | 90024 | — |
| GSK Investigational Site | Los Angeles | California | 90036 | — |
| GSK Investigational Site | Madera | California | 93637 | — |
| GSK Investigational Site | Oakland | California | 94611 | — |
| GSK Investigational Site | Oakland | California | 94612 | — |
| GSK Investigational Site | Poway | California | 92064 | — |
| GSK Investigational Site | Sacramento | California | 95819 | — |
| GSK Investigational Site | San Diego | California | 92161 | — |
| GSK Investigational Site | San Ramon | California | 94582 | — |
| GSK Investigational Site | Santa Ana | California | 92705 | — |
| GSK Investigational Site | Spring Valley | California | 91978 | — |
| GSK Investigational Site | Thousand Oaks | California | 91360 | — |
| GSK Investigational Site | Colorado Springs | Colorado | 80920 | — |
| GSK Investigational Site | Denver | Colorado | 80218 | — |
| GSK Investigational Site | Golden | Colorado | 80401 | — |
| GSK Investigational Site | Thornton | Colorado | 80229 | — |
| GSK Investigational Site | Bridgeport | Connecticut | 06606 | — |
| GSK Investigational Site | Bridgeport | Connecticut | 06610 | — |
| GSK Investigational Site | Hartford | Connecticut | 06067 | — |
| GSK Investigational Site | Newark | Delaware | 19718 | — |
| GSK Investigational Site | Atlantis | Florida | 33462 | — |
| GSK Investigational Site | Gainesville | Florida | 32610 | — |
| GSK Investigational Site | Hollywood | Florida | 33023 | — |
| GSK Investigational Site | Jacksonville | Florida | 32207 | — |
| GSK Investigational Site | Jacksonville | Florida | 32216 | — |
| GSK Investigational Site | Jacksonville | Florida | 32258 | — |
| GSK Investigational Site | Jacksonville Beach | Florida | 32250 | — |
| GSK Investigational Site | Miami | Florida | 33136 | — |
| GSK Investigational Site | Miami | Florida | 33183 | — |
| GSK Investigational Site | Ocala | Florida | 34471 | — |
| GSK Investigational Site | Ponte Vedra Beach | Florida | 32081 | — |
| GSK Investigational Site | Conyers | Georgia | 30094 | — |
| GSK Investigational Site | Aurora | Illinois | 60504 | — |
| GSK Investigational Site | Chicago | Illinois | 60654 | — |
| GSK Investigational Site | Melrose Park | Illinois | 60160 | — |
| GSK Investigational Site | Avon | Indiana | 46123 | — |
| GSK Investigational Site | Franklin | Indiana | 46131 | — |
| GSK Investigational Site | Greenfield | Indiana | 46140 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46256 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46260 | — |
| GSK Investigational Site | Valparaiso | Indiana | 46383 | — |
| GSK Investigational Site | Iowa City | Iowa | 52242 | — |
| GSK Investigational Site | West Des Moines | Iowa | 50266 | — |
| GSK Investigational Site | Crestview Hills | Kentucky | 41017 | — |
| GSK Investigational Site | Louisville | Kentucky | 40206 | — |
| GSK Investigational Site | Louisville | Kentucky | 40213 | — |
| GSK Investigational Site | Lafayette | Louisiana | 70503 | — |
| GSK Investigational Site | New Iberia | Louisiana | 70563 | — |
| GSK Investigational Site | Slidell | Louisiana | 70458 | — |
| GSK Investigational Site | Auburn | Maine | 04210 | — |
| GSK Investigational Site | Bangor | Maine | 04401 | — |
| GSK Investigational Site | Scarborough | Maine | 04074 | — |
| GSK Investigational Site | Baltimore | Maryland | 21209 | — |
| GSK Investigational Site | Oxon Hill | Maryland | 20745 | — |
| GSK Investigational Site | Prince Frederick | Maryland | 20678 | — |
| GSK Investigational Site | Boston | Massachusetts | 02111 | — |
| GSK Investigational Site | Natick | Massachusetts | 01760 | — |
| GSK Investigational Site | Springfield | Massachusetts | 01103 | — |
| GSK Investigational Site | Cadillac | Michigan | 49601 | — |
| GSK Investigational Site | Detroit | Michigan | 48202 | — |
| GSK Investigational Site | Petoskey | Michigan | 49770 | — |
| GSK Investigational Site | Saint Cloud | Minnesota | 56303 | — |
| GSK Investigational Site | St Louis | Missouri | 63110 | — |
| GSK Investigational Site | Grand Island | Nebraska | 68803 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89103 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89130 | — |
| GSK Investigational Site | Browns Mills | New Jersey | 08015 | — |
| GSK Investigational Site | Elizabeth | New Jersey | 07202 | — |
| GSK Investigational Site | West Orange | New Jersey | 07052 | — |
| GSK Investigational Site | Albuquerque | New Mexico | 87102 | — |
| GSK Investigational Site | Buffalo | New York | 14215 | — |
| GSK Investigational Site | New York | New York | 10001 | — |
| GSK Investigational Site | New York | New York | 10016 | — |
| GSK Investigational Site | New York | New York | 10021 | — |
| GSK Investigational Site | Westfield | New York | 14787 | — |
| GSK Investigational Site | Williamsville | New York | 14221 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28204 | — |
| GSK Investigational Site | Durham | North Carolina | 27710 | — |
| GSK Investigational Site | Gastonia | North Carolina | 28054 | — |
| GSK Investigational Site | Matthews | North Carolina | 28105 | — |
| GSK Investigational Site | Salisbury | North Carolina | 28144 | — |
| GSK Investigational Site | Statesville | North Carolina | 28677 | — |
| GSK Investigational Site | Wilmington | North Carolina | 28401 | — |
| GSK Investigational Site | Grand Forks | North Dakota | 58201 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45227 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45246 | — |
| GSK Investigational Site | Elyria | Ohio | 44035 | — |
| GSK Investigational Site | Garfield Heights | Ohio | 44125 | — |
| GSK Investigational Site | Kettering | Ohio | 45429 | — |
| GSK Investigational Site | Middleburg Heights | Ohio | 44130 | — |
| GSK Investigational Site | Sandusky | Ohio | 44870 | — |
| GSK Investigational Site | Toledo | Ohio | 43614 | — |
| GSK Investigational Site | Westlake | Ohio | 44145 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| GSK Investigational Site | Portland | Oregon | 97219 | — |
| GSK Investigational Site | Beaver | Pennsylvania | 15009 | — |
| GSK Investigational Site | Danville | Pennsylvania | 17822-4201 | — |
| GSK Investigational Site | Doylestown | Pennsylvania | 18901 | — |
| GSK Investigational Site | Erie | Pennsylvania | 16502 | — |
| GSK Investigational Site | Jersey Shore | Pennsylvania | 17740 | — |
| GSK Investigational Site | Lewistown | Pennsylvania | 17044 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| GSK Investigational Site | Philipsburg | Pennsylvania | 16866 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| GSK Investigational Site | Port Matilda | Pennsylvania | 16870 | — |
| GSK Investigational Site | Sayre | Pennsylvania | 18840 | — |
| GSK Investigational Site | Scranton | Pennsylvania | 18503 | — |
| GSK Investigational Site | Scranton | Pennsylvania | 18505 | — |
| GSK Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| GSK Investigational Site | Wilkes-Barre | Pennsylvania | 18702 | — |
| GSK Investigational Site | York | Pennsylvania | 17403 | — |
| GSK Investigational Site | Providence | Rhode Island | 02904 | — |
| GSK Investigational Site | Charleston | South Carolina | 29401 | — |
| GSK Investigational Site | Charleston | South Carolina | 29425-6240 | — |
| GSK Investigational Site | Spartanburg | South Carolina | 29303 | — |
| GSK Investigational Site | Rapid City | South Dakota | 57701 | — |
| GSK Investigational Site | Sioux Falls | South Dakota | 57105 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Johnson City | Tennessee | 37601 | — |
| GSK Investigational Site | Amarillo | Texas | 79106 | — |
| GSK Investigational Site | Austin | Texas | 78705 | — |
| GSK Investigational Site | Corpus Christi | Texas | 78404 | — |
| GSK Investigational Site | Dallas | Texas | 75226 | — |
| GSK Investigational Site | Dallas | Texas | 75231 | — |
| GSK Investigational Site | Georgetown | Texas | 78626 | — |
| GSK Investigational Site | Harker Heights | Texas | 76548 | — |
| GSK Investigational Site | Houston | Texas | 77030 | — |
| GSK Investigational Site | Houston | Texas | 77081 | — |
| GSK Investigational Site | Plano | Texas | 75024 | — |
| GSK Investigational Site | San Antonio | Texas | 78217 | — |
| GSK Investigational Site | San Antonio | Texas | 78244 | — |
| GSK Investigational Site | Victoria | Texas | 77901 | — |
| GSK Investigational Site | Draper | Utah | 84020 | — |
| GSK Investigational Site | Burke | Virginia | 22015 | — |
| GSK Investigational Site | Norfolk | Virginia | 23502 | — |
| GSK Investigational Site | Richmond | Virginia | 23294 | — |
| GSK Investigational Site | Winchester | Virginia | 22601 | — |
| GSK Investigational Site | Kirkland | Washington | 98034 | — |
| GSK Investigational Site | Olympia | Washington | 98502 | — |
| GSK Investigational Site | Renton | Washington | 98057 | — |
| GSK Investigational Site | Seattle | Washington | 98104 | — |
| GSK Investigational Site | Spokane | Washington | 99204 | — |
| GSK Investigational Site | Spokane | Washington | 99207 | — |
| GSK Investigational Site | Spokane | Washington | 99208 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
| GSK Investigational Site | Walla Walla | Washington | 99362 | — |
| GSK Investigational Site | Wenatchee | Washington | 98801 | — |
| GSK Investigational Site | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 495 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00799903, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00799903 live on ClinicalTrials.gov.